DK194377A - Pyrrolidoner samt deres fremstilling og anvendelse - Google Patents
Pyrrolidoner samt deres fremstilling og anvendelseInfo
- Publication number
- DK194377A DK194377A DK194377A DK194377A DK194377A DK 194377 A DK194377 A DK 194377A DK 194377 A DK194377 A DK 194377A DK 194377 A DK194377 A DK 194377A DK 194377 A DK194377 A DK 194377A
- Authority
- DK
- Denmark
- Prior art keywords
- pyrrolidones
- manufacture
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000004040 pyrrolidinones Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762619638 DE2619638A1 (de) | 1976-05-04 | 1976-05-04 | Pyrrolidone und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK194377A true DK194377A (da) | 1977-11-05 |
Family
ID=5977020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK194377A DK194377A (da) | 1976-05-04 | 1977-05-03 | Pyrrolidoner samt deres fremstilling og anvendelse |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS52133975A (fr) |
| BE (1) | BE854268A (fr) |
| DE (1) | DE2619638A1 (fr) |
| DK (1) | DK194377A (fr) |
| ES (1) | ES458264A1 (fr) |
| FR (1) | FR2372806A1 (fr) |
| GB (1) | GB1583163A (fr) |
| IT (1) | IT1086223B (fr) |
| NL (1) | NL7704739A (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4320136A (en) | 1980-08-11 | 1982-03-16 | E. I. Du Pont De Nemours And Company | 8-Aza-16,16-difluoroprostanoids |
| US4321201A (en) | 1980-09-22 | 1982-03-23 | E. I. Du Pont De Nemours And Company | Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates |
| JPH03500534A (ja) * | 1988-04-22 | 1991-02-07 | 2 モスコフスキ ゴスダルストベンニ メディツィンスキ インスティテュト イメニ エヌー.イー.ピロゴバ | ラクタム‐1‐酢酸カルボアルコキシメチルエステル及びその製造方法 |
| EA005293B1 (ru) * | 1999-12-22 | 2004-12-30 | Пфайзер Продактс Инк. | Производные пирролидин-2-она и их применение при лечении остеопороза |
| WO2002024647A1 (fr) * | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine |
| EA200300379A1 (ru) | 2000-11-27 | 2003-08-28 | Пфайзер Продактс Инк. | Селективные агонисты рецептора ep4 в лечении остеопороза |
| RU2288913C2 (ru) * | 2001-07-16 | 2006-12-10 | Ф.Хоффманн-Ля Рош Аг | Аналоги простагландинов, способ их получения и фармацевтическая композиция, обладающая селективной агонистической активностью в отношении рецептора ep4 |
| RU2296122C2 (ru) | 2001-07-16 | 2007-03-27 | Ф.Хоффманн-Ля Рош Аг | Производные 2-пирролидона в качестве простаноидных агонистов и фармацевтическая композиция |
| IL159996A0 (en) | 2001-07-23 | 2004-06-20 | Ono Pharmaceutical Co | Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient |
| JP4547912B2 (ja) | 2002-03-05 | 2010-09-22 | 小野薬品工業株式会社 | 8−アザプロスタグランジン誘導体化合物およびその化合物を有効成分として含有する薬剤 |
| JP4754820B2 (ja) * | 2002-06-10 | 2011-08-24 | メルク セローノ ソシエテ アノニム | プロスタグランジン作動薬としてのγラクタムおよびその使用 |
| CN1735597A (zh) | 2003-01-10 | 2006-02-15 | 霍夫曼-拉罗奇有限公司 | 作为前列腺素激动剂的2-哌啶酮衍生物 |
| JP4582456B2 (ja) * | 2003-01-21 | 2010-11-17 | 小野薬品工業株式会社 | 8−アザプロスタグランジン誘導体およびその医薬用途 |
| US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| JP4893999B2 (ja) | 2004-10-22 | 2012-03-07 | 小野薬品工業株式会社 | 吸入用医薬組成物 |
| US9440919B2 (en) | 2012-07-19 | 2016-09-13 | Cayman Chemical Company, Inc. | Difluorolactam compositions for EP4-mediated osteo related diseases and conditions |
| ES2635635T3 (es) * | 2013-03-15 | 2017-10-04 | Cayman Chemical Company, Incorporated | Compuestos de difluorolactama como agonistas selectivos del receptor EP4 para su uso en el tratamiento de enfermedades y afecciones mediadas por EP4 |
| WO2014144610A1 (fr) * | 2013-03-15 | 2014-09-18 | Cayman Chemical Company, Inc. | Composés lactames en tant qu'agonistes sélectifs du récepteur ep4 pour l'utilisation dans le traitement de maladies et d'états à médiation par ep4 |
| JP6368351B2 (ja) | 2013-03-15 | 2018-08-01 | ケイマン ケミカル カンパニー, インコーポレーテッド | ジフルオロラクタムアナログを合成する方法 |
| EP3021879A2 (fr) | 2013-07-19 | 2016-05-25 | Cayman Chemical Company, Incorporated | Procédés, systèmes et compositions pour activer la croissance osseuse |
-
1976
- 1976-05-04 DE DE19762619638 patent/DE2619638A1/de active Pending
-
1977
- 1977-04-28 ES ES458264A patent/ES458264A1/es not_active Expired
- 1977-04-29 NL NL7704739A patent/NL7704739A/xx not_active Application Discontinuation
- 1977-05-02 IT IT23096/77A patent/IT1086223B/it active
- 1977-05-03 GB GB18427/77A patent/GB1583163A/en not_active Expired
- 1977-05-03 DK DK194377A patent/DK194377A/da unknown
- 1977-05-04 BE BE177278A patent/BE854268A/fr unknown
- 1977-05-04 JP JP5194577A patent/JPS52133975A/ja active Pending
- 1977-05-04 FR FR7713518A patent/FR2372806A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| GB1583163A (en) | 1981-01-21 |
| NL7704739A (nl) | 1977-11-08 |
| FR2372806A1 (fr) | 1978-06-30 |
| BE854268A (fr) | 1977-11-04 |
| FR2372806B1 (fr) | 1980-02-29 |
| JPS52133975A (en) | 1977-11-09 |
| DE2619638A1 (de) | 1977-11-17 |
| IT1086223B (it) | 1985-05-28 |
| ES458264A1 (es) | 1978-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK120077A (da) | Cycliske sulfonyloxiimider samt deres fremstilling og anvendelse | |
| DK194377A (da) | Pyrrolidoner samt deres fremstilling og anvendelse | |
| DK56876A (da) | Prostaglandinanaloge samt deres fremstilling og anvendelse | |
| DK248177A (da) | Guanidinderivater samt deres fremstilling og anvendelse | |
| DK287476A (da) | Pyrrolidoner samt deres fremstilling og anvendelse | |
| DK358678A (da) | 1,4-bis-amino-anthraquinonforbindelser samt deres anvendelse og fremstilling | |
| DK407577A (da) | Azabicycloforbindelser samt deres fremstilling og anvendelse | |
| DK154877A (da) | Trans-hexahydro-pyrido-indoler samt deres fremstilling og anvendelse | |
| DK97179A (da) | Bicyclooctanderivater samt deres fremstilling og anvendelse | |
| DK474678A (da) | Halogenvinyl-gamma-butyrolactoner samt deres fremstilling og anvendelse | |
| DK83677A (da) | Pyrrolbenzoxazalkaner samt deres fremstilling og anvendelse | |
| DK214577A (da) | Benzensulfonylurinstoffer deres fremstilling og anvendelse | |
| DK513678A (da) | Indolderivater samt deres fremstilling og anvendelse | |
| DK299578A (da) | Bleomyciner samt deres fremstilling og anvendelse | |
| DK227177A (da) | 1-aryloxy-2-hydroxy-3-aminopropaner samt deres fremstilling og anvendelse | |
| DK581577A (da) | Dehydrooligopeptider samt deres fremstilling og anvendelse | |
| DK254077A (da) | Benzylcyanocetaler deres fremstilling og anvendelse | |
| DK554776A (da) | Prostaglandinanaloge pyrrolidoner samt deres fremstilling og anvendelse | |
| DK279777A (da) | Carbostyriler samt deres fremstilling og anvendelse | |
| DK281476A (da) | Pyrrolidoner samt deres fremstilling og anvendelse | |
| DK565277A (da) | Imidazoliner deres fremstilling og anvendelse | |
| DK137778A (da) | Prostansyrederivater samt deres fremstilling og anvendelse | |
| DK574976A (da) | Substituerede cycloalkanpyrazoler samt deres fremstilling og anvendelse | |
| DK84377A (da) | Substituerede phenylguanidiner samt deres fremstilling og anvendelse | |
| DK582378A (da) | Simipermeable membraner samt deres fremstilling og anvendelse |